Interestingly, in the tumors of MIP-treated animals, the fraction of transferred Tregs (CFSE+) within intratumoral total CFSE+ T cells were reduced to almost half of the percentage of CFSE+ Tregs migrated in tumor of control mice. The gene discussed is MIP; the disease is neoplasm.